Thursday, February 27, 2020

Latest:

It’s Heart Month!
‘Saturday Morning Science’ inspires medical student to give back to community
Pediatric plastic surgeon helps patients thrive through literature
Understanding fatty liver disease key to liver cancer prevention
Congratulations to the recipients of CPRIT grants for cancer research!

Baylor College of Medicine Blog Network

Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
PolicyWise
- About PolicyWise
- Follow @BCMEthics on Twitter
Progress Notes
- About Progress Notes
- Connect With Us
bcm.edu

lapatinib

From The Labs

De-escalating breast cancer therapy; can some patients be spared chemotherapy?

June 25, 2019June 25, 2019 Ana Rodríguez 1 Comment Breast Cancer, Chemotherapy, Clinical Trials, HER2 gene, lapatinib, PI3K pathway, Research, trastuzumab

About one of every five breast cancers presents with high levels of HER2 proteins. Known as HER2-positive breast cancer, these

Baylor College of Medicine experts Drs. Pedro A. Piedra and Robert Atmar share facts you should know about the novel coronavirus outbreak.

From the Labs Image of the Month

From the Labs features an image of human breast epithelial cells. These cells can transform into carcinomas, which represent the vast majority of breast cancers.